Production (Stage)
Microbix Biosystems Inc.
MBX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.71M | 4.32M | 4.61M | 3.70M | 4.18M |
| Total Other Revenue | -- | -- | 0.00 | -- | -- |
| Total Revenue | 3.71M | 4.32M | 4.61M | 3.70M | 4.18M |
| Cost of Revenue | 1.50M | 1.64M | 2.08M | 1.69M | 1.97M |
| Gross Profit | 2.21M | 2.68M | 2.53M | 2.01M | 2.20M |
| SG&A Expenses | 1.73M | 1.56M | 1.58M | 1.48M | 1.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.59M | 3.62M | 4.09M | 3.58M | 3.84M |
| Operating Income | 124.50K | 693.00K | 521.10K | 120.80K | 340.50K |
| Income Before Tax | 14.40K | 612.20K | 433.20K | 180.30K | 280.20K |
| Income Tax Expenses | -- | -- | 110.40K | -- | -- |
| Earnings from Continuing Operations | 14.40K | 612.20K | 322.80K | 180.30K | 280.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.40K | 612.20K | 322.80K | 180.30K | 280.20K |
| EBIT | 124.50K | 693.00K | 521.10K | 120.80K | 340.50K |
| EBITDA | 422.70K | 947.80K | 756.30K | 432.60K | 640.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 139.85M | 134.91M | 136.31M | 136.84M | 137.37M |
| Average Diluted Shares Outstanding | 140.62M | 135.55M | 137.06M | 137.63M | 139.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |